583 related articles for article (PubMed ID: 25916335)
1. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
Gaul C; Diener HC; Danesch U;
J Headache Pain; 2015; 16():516. PubMed ID: 25916335
[TBL] [Abstract][Full Text] [Related]
2. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
[TBL] [Abstract][Full Text] [Related]
3. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis.
Bianchi A; Salomone S; Caraci F; Pizza V; Bernardini R; D'Amato CC
Vitam Horm; 2004; 69():297-312. PubMed ID: 15196887
[TBL] [Abstract][Full Text] [Related]
4. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of nutraceuticals in migraine prophylaxis.
D'Onofrio F; Raimo S; Spitaleri D; Casucci G; Bussone G
Neurol Sci; 2017 May; 38(Suppl 1):117-120. PubMed ID: 28527067
[TBL] [Abstract][Full Text] [Related]
6. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
Maizels M; Blumenfeld A; Burchette R
Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine.
Slater SK; Nelson TD; Kabbouche MA; LeCates SL; Horn P; Segers A; Manning P; Powers SW; Hershey AD
Cephalalgia; 2011 Jun; 31(8):897-905. PubMed ID: 21586650
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
9. Diamine oxidase (DAO) supplement reduces headache in episodic migraine patients with DAO deficiency: A randomized double-blind trial.
Izquierdo-Casas J; Comas-Basté O; Latorre-Moratalla ML; Lorente-Gascón M; Duelo A; Soler-Singla L; Vidal-Carou MC
Clin Nutr; 2019 Feb; 38(1):152-158. PubMed ID: 29475774
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
11. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
[TBL] [Abstract][Full Text] [Related]
13. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.
Sándor PS; Di Clemente L; Coppola G; Saenger U; Fumal A; Magis D; Seidel L; Agosti RM; Schoenen J
Neurology; 2005 Feb; 64(4):713-5. PubMed ID: 15728298
[TBL] [Abstract][Full Text] [Related]
15. Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study.
Pfaffenrath V; Wessely P; Meyer C; Isler HR; Evers S; Grotemeyer KH; Taneri Z; Soyka D; Göbel H; Fischer M
Cephalalgia; 1996 Oct; 16(6):436-40. PubMed ID: 8902254
[TBL] [Abstract][Full Text] [Related]
16. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
17. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
[TBL] [Abstract][Full Text] [Related]
18. Plasma ubiquinone status and response to six-month supplementation combined with multivitamins in healthy elderly women--results of a randomized, double-blind, placebo-controlled study.
Wolters M; Hahn A
Int J Vitam Nutr Res; 2003 May; 73(3):207-14. PubMed ID: 12847998
[TBL] [Abstract][Full Text] [Related]
19. Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers.
Dahri M; Tarighat-Esfanjani A; Asghari-Jafarabadi M; Hashemilar M
Nutr Neurosci; 2019 Sep; 22(9):607-615. PubMed ID: 29298622
[No Abstract] [Full Text] [Related]
20. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
